Literature DB >> 12604509

Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary.

Jacques Grosset1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12604509      PMCID： PMC149338          DOI： 10.1128/AAC.47.3.833-836.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  12 in total

Review 1.  Tuberculosis: latency and reactivation.

Authors:  J L Flynn; J Chan
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

2.  The pathogenesis of tuberculous cavities.

Authors:  Y YAMAMURA
Journal:  Bibl Tuberc       Date:  1958

3.  Infectivity of pulmonary tuberculosis in relation to sputum status.

Authors:  J B SHAW; N WYNN-WILLIAMS
Journal:  Am Rev Tuberc       Date:  1954-05

4.  Contacts of cases of active pulmonary tuberculosis.

Authors:  S Grzybowski; G D Barnett; K Styblo
Journal:  Bull Int Union Tuberc       Date:  1975

5.  Aerial transmission of mycobacteria.

Authors:  R G Loudon; L R Bumgarner; J Lacy; G K Coffman
Journal:  Am Rev Respir Dis       Date:  1969-08

Review 6.  Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli.

Authors:  I Sutherland
Journal:  Adv Tuberc Res       Date:  1976

Review 7.  Bacteriologic basis of short-course chemotherapy for tuberculosis.

Authors:  J Grosset
Journal:  Clin Chest Med       Date:  1980-05       Impact factor: 2.878

8.  Airborne infection.

Authors:  R L Riley
Journal:  Am J Med       Date:  1974-09       Impact factor: 4.965

9.  Tuberculosis Surveillance Research Unit Report No. 1: the transmission of tubercle bacilli; its trend in a human population.

Authors:  K Stýblo; J Meijer; I Sutherland
Journal:  Bull Int Union Tuberc       Date:  1969-08

10.  Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis.

Authors: 
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408
View more
  83 in total

1.  Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis.

Authors:  Ian M Rosenthal; Rokeya Tasneen; Charles A Peloquin; Ming Zhang; Deepak Almeida; Khisimuzi E Mdluli; Petros C Karakousis; Jacques H Grosset; Eric L Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

2.  Genetic control of immune-mediated necrosis of Mycobacterium avium granulomas.

Authors:  Manuela Flórido; Rui Appelberg
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 3.  Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections.

Authors:  E Nuermberger; J Grosset
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-13       Impact factor: 3.267

Review 4.  ppGpp conjures bacterial virulence.

Authors:  Zachary D Dalebroux; Sarah L Svensson; Erin C Gaynor; Michele S Swanson
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

5.  The stringent response is required for full virulence of Mycobacterium tuberculosis in guinea pigs.

Authors:  Lee G Klinkenberg; Jong-Hee Lee; William R Bishai; Petros C Karakousis
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

6.  Treatment-Shortening Effect of a Novel Regimen Combining Clofazimine and High-Dose Rifapentine in Pathologically Distinct Mouse Models of Tuberculosis.

Authors:  Vikram Saini; Nicole C Ammerman; Yong Seok Chang; Rokeya Tasneen; Richard E Chaisson; Sanjay Jain; Eric Nuermberger; Jacques H Grosset
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

7.  Construction and evaluation of luciferase reporter phages for the detection of active and non-replicating tubercle bacilli.

Authors:  Azger Dusthackeer; Vanaja Kumar; Selvakumar Subbian; Gomathi Sivaramakrishnan; Guofang Zhu; Balaji Subramanyam; Sameer Hassan; Selvakumar Nagamaiah; John Chan; Narayanan Paranji Rama
Journal:  J Microbiol Methods       Date:  2008-01-19       Impact factor: 2.363

Review 8.  The protective role of antibody responses during Mycobacterium tuberculosis infection.

Authors:  F Abebe; G Bjune
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

9.  Repetitive Aerosol Exposure Promotes Cavitary Tuberculosis and Enables Screening for Targeted Inhibitors of Extensive Lung Destruction.

Authors:  Michael E Urbanowski; Elizabeth A Ihms; Kristina Bigelow; André Kübler; Paul T Elkington; William R Bishai
Journal:  J Infect Dis       Date:  2018-06-05       Impact factor: 5.226

10.  Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.

Authors:  John D Szumowski; Kristin N Adams; Paul H Edelstein; Lalita Ramakrishnan
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.